Icon Plc (ICLR)

$121.94 +2.98 (2.51%)
Market Cap 9.61B
Revenue (ttm) 8.28B
Net Income (ttm) 791.47M
EPS (ttm) N/A
PE Ratio 9.98
Forward PE 10.79
Profit Margin 9.56%
Debt to Equity Ratio 0.37
Volume 803,600
Avg Vol 1,159,886
Day's Range N/A - N/A
Shares Out 80.76M
Stochastic %K 63%
Beta 1.23
Analysts Sell
Price Target $133.54

Company Profile

ICON Public Limited Company, a clinical research organization, provides outsourced development and commercialization services in Ireland, rest of Europe, the United States, and internationally. The company specializes in the strategic development, management, and analysis of programs that support various stages of the clinical development process from compound selection to Phase I-IV clinical studies. It also provides clinical development services, including all phases of development, peri and p...

Industry: Diagnostics & Research
Sector: Healthcare
Phone: 353 1 291 2000
Fax: 353 1 247 6260
Address:
South County Business Park, Leopardstown, Dublin, Ireland
CapitalMonk
CapitalMonk May. 13 at 3:21 AM
$ICLR Price: $121.94 (+2.51%) Trend: Bearish Market Bias (7D): Sideways ⚖️ Expected Range: ±0.30% RSI: 55.5 | Momentum: Moderate Volume: -47.5% vs avg Volatility: 4.64% Support: $99.06 | Resistance: $129.73 Tools used: https://www.trade-ideas.com Code: INTERSTOCK25
0 · Reply
sandeeprk
sandeeprk May. 7 at 1:42 PM
$ICLR this is going to be 200+ after ER
0 · Reply
sandeeprk
sandeeprk May. 6 at 12:22 PM
$ICLR wow
1 · Reply
sandeeprk
sandeeprk May. 5 at 4:55 PM
$ICLR on the way to 160
0 · Reply
sandeeprk
sandeeprk May. 4 at 2:56 PM
$ICLR going to 160+ after ER
0 · Reply
STACKD0E
STACKD0E May. 4 at 12:05 AM
$ICLR
0 · Reply
RedCandleRandy
RedCandleRandy May. 3 at 2:37 PM
$ICLR added
0 · Reply
sandeeprk
sandeeprk May. 1 at 8:45 PM
$ICLR why up ? are the earnings out ??
1 · Reply
StockConsultant
StockConsultant May. 1 at 1:20 PM
$ICLR Icon stock, watch for an upside gap breakout at https://stockconsultant.com/?ICLR
0 · Reply
A___A
A___A May. 1 at 12:14 AM
$ICLR weren't they supposed to release FY25 earnings today?
1 · Reply
Latest News on ICLR
HealthVerity to Acquire Symphony Health, Uniting Clinical Data and Commercial Analytics to Accelerate Breakthroughs Across the Healthcare Ecosystem

May 5, 2026, 8:00 AM EDT - 7 days ago

HealthVerity to Acquire Symphony Health, Uniting Clinical Data and Commercial Analytics to Accelerate Breakthroughs Across the Healthcare Ecosystem

Icon price target raised to $125 from $105 at Leerink

2026-05-04T10:01:26.000Z - 9 days ago

Icon price target raised to $125 from $105 at Leerink

Icon says Audit Committee completes investigation into accounting practices

2026-04-29T13:14:01.000Z - 13 days ago

Icon says Audit Committee completes investigation into accounting practices

ICON Provides Update on Audit Committee Investigation and Timing of Fourth Quarter and Full Year 2025 Financial Results

Apr 29, 2026, 7:00 AM EDT - 13 days ago

ICON Provides Update on Audit Committee Investigation and Timing of Fourth Quarter and Full Year 2025 Financial Results

ICON plc options imply 12.4% move in share price post-earnings

2026-04-27T19:25:12.000Z - 15 days ago

ICON plc options imply 12.4% move in share price post-earnings

ICON plc options imply 11.5% move in share price post-earnings

2026-04-20T18:21:28.000Z - 22 days ago

ICON plc options imply 11.5% move in share price post-earnings

ICON plc options imply 9.7% move in share price post-earnings

2026-04-16T17:35:15.000Z - 26 days ago

ICON plc options imply 9.7% move in share price post-earnings

Icon upgraded to Outperform from Market Perform at BMO Capital

2026-03-26T08:30:23.000Z - 6 weeks ago

Icon upgraded to Outperform from Market Perform at BMO Capital

Icon, Advarra enter partnership, introduces ‘research-ready’ site network model

2026-03-24T12:15:33.000Z - 7 weeks ago

Icon, Advarra enter partnership, introduces ‘research-ready’ site network model

ICON and Advarra Introduce New ‘Research-Ready,' Connected Site Network Model

Mar 24, 2026, 8:00 AM EDT - 7 weeks ago

ICON and Advarra Introduce New ‘Research-Ready,' Connected Site Network Model

Lowey Dannenberg, P.C. is Investigating ICON PLC (NASDAQ: ICLR) for Potential Violations of the Federal Securities Laws and Encourages Investors to Contact the Firm

Mar 16, 2026, 11:02 AM EDT - 2 months ago

Lowey Dannenberg, P.C. is Investigating ICON PLC (NASDAQ: ICLR) for Potential Violations of the Federal Securities Laws and Encourages Investors to Contact the Firm

ICON plc options imply 2.8% move in share price post-earnings

2026-03-13T17:50:15.000Z - 2 months ago

ICON plc options imply 2.8% move in share price post-earnings

Icon price target lowered to $120 from $200 at Citi

2026-03-11T10:00:29.000Z - 2 months ago

Icon price target lowered to $120 from $200 at Citi

ICON plc options imply 4.1% move in share price post-earnings

2026-03-06T18:35:16.000Z - 2 months ago

ICON plc options imply 4.1% move in share price post-earnings

Icon price target lowered to $120 from $200 at Barclays

2026-03-06T11:31:20.000Z - 2 months ago

Icon price target lowered to $120 from $200 at Barclays

Ademi LLP Investigates Claims of Securities Fraud against ICON plc

Feb 26, 2026, 9:06 AM EST - 2 months ago

Ademi LLP Investigates Claims of Securities Fraud against ICON plc

Icon upgraded to Buy from Hold at Jefferies

2026-02-23T09:46:03.000Z - 2 months ago

Icon upgraded to Buy from Hold at Jefferies

ICON plc Faces Investigation After Internal Probe Reveals Multi-Year Revenue Overstatement

Feb 18, 2026, 9:00 AM EST - 2 months ago

ICON plc Faces Investigation After Internal Probe Reveals Multi-Year Revenue Overstatement

Icon upgraded to Buy from Hold at TD Cowen

2026-02-18T10:40:15.000Z - 3 months ago

Icon upgraded to Buy from Hold at TD Cowen

Icon downgraded to Neutral from Buy at Rothschild & Co Redburn

2026-02-17T10:00:14.000Z - 3 months ago

Icon downgraded to Neutral from Buy at Rothschild & Co Redburn

Icon price target lowered to $119 from $217 at Baird

2026-02-13T14:26:04.000Z - 3 months ago

Icon price target lowered to $119 from $217 at Baird

Icon price target lowered to $100 from $175 at BMO Capital

2026-02-13T13:00:53.000Z - 3 months ago

Icon price target lowered to $100 from $175 at BMO Capital

Why this drug-research company's stock is having its worst day since 1999

Feb 12, 2026, 11:10 AM EST - 3 months ago

Why this drug-research company's stock is having its worst day since 1999

ICON PLC (ICLR) Shareholders Are Encouraged to Reach Out to Johnson Fistel for More Information About Potentially Recovering Their Losses

Feb 12, 2026, 10:15 AM EST - 3 months ago

ICON PLC (ICLR) Shareholders Are Encouraged to Reach Out to Johnson Fistel for More Information About Potentially Recovering Their Losses

ICON plc Provides Update on Timing of Fourth Quarter and Full Year 2025 Earnings Results and Investigation into Accounting Practices

Feb 12, 2026, 6:00 AM EST - 3 months ago

ICON plc Provides Update on Timing of Fourth Quarter and Full Year 2025 Earnings Results and Investigation into Accounting Practices

ICON's Accellacare Site Network Expands Oncology Research Capabilities With New Cancer Institute Partnership

Jan 27, 2026, 7:15 AM EST - 3 months ago

ICON's Accellacare Site Network Expands Oncology Research Capabilities With New Cancer Institute Partnership

ICON 2025 global biotech survey solidifies China dominance and highlights opportunities for Western biotechs to stay competitive

Dec 9, 2025, 7:15 AM EST - 5 months ago

ICON 2025 global biotech survey solidifies China dominance and highlights opportunities for Western biotechs to stay competitive

ICON Survey Reveals Increasing Clinical Trial Startup Delays, Underscoring Need for Human-Centred Site Activation Solutions

Dec 2, 2025, 7:15 AM EST - 5 months ago

ICON Survey Reveals Increasing Clinical Trial Startup Delays, Underscoring Need for Human-Centred Site Activation Solutions

ICON Public Limited Company Transcript: Jefferies London Healthcare Conference 2025

Nov 19, 2025, 4:00 AM EST - 6 months ago

ICON Public Limited Company Transcript: Jefferies London Healthcare Conference 2025

ICON plc to Present at the Jefferies London Healthcare Conference

Nov 12, 2025, 6:45 AM EST - 6 months ago

ICON plc to Present at the Jefferies London Healthcare Conference

ICON Public Limited Company Earnings Call Transcript: Q3 2025

Oct 23, 2025, 8:00 AM EDT - 7 months ago

ICON Public Limited Company Earnings Call Transcript: Q3 2025

ICON Reports Third Quarter 2025 Results

Oct 22, 2025, 4:25 PM EDT - 7 months ago

ICON Reports Third Quarter 2025 Results

ICON plc Schedules Third Quarter 2025 Earnings Conference Call

Sep 24, 2025, 9:00 AM EDT - 8 months ago

ICON plc Schedules Third Quarter 2025 Earnings Conference Call

ICON Public Limited Company Transcript: Baird Global Healthcare Conference 2025

Sep 10, 2025, 1:25 PM EDT - 8 months ago

ICON Public Limited Company Transcript: Baird Global Healthcare Conference 2025

ICON Announces CEO Transition

Sep 4, 2025, 8:00 AM EDT - 8 months ago

ICON Announces CEO Transition

ICON plc to Participate at Upcoming Investor Conferences

Sep 2, 2025, 6:00 AM EDT - 9 months ago

ICON plc to Participate at Upcoming Investor Conferences

ICON Public Limited Company Earnings Call Transcript: Q2 2025

Jul 24, 2025, 8:00 AM EDT - 10 months ago

ICON Public Limited Company Earnings Call Transcript: Q2 2025

ICON Announces Results of Annual General Meeting

Jul 23, 2025, 4:20 PM EDT - 10 months ago

ICON Announces Results of Annual General Meeting

ICON Reports Second Quarter 2025 Results

Jul 23, 2025, 4:15 PM EDT - 10 months ago

ICON Reports Second Quarter 2025 Results

ICON's Leadership and Performance in Phase 1 Clinical Trials Recognised in Independent Industry Benchmarking Report

Jul 16, 2025, 7:15 AM EDT - 10 months ago

ICON's Leadership and Performance in Phase 1 Clinical Trials Recognised in Independent Industry Benchmarking Report

ICON and Its Employees Recognised as Clinical Research Industry Leaders, and for Innovation and Progress in Sustainability

Jul 7, 2025, 7:15 AM EDT - 11 months ago

ICON and Its Employees Recognised as Clinical Research Industry Leaders, and for Innovation and Progress in Sustainability

ICON plc Schedules Second Quarter 2025 Earnings Conference Call

Jun 23, 2025, 6:30 AM EDT - 11 months ago

ICON plc Schedules Second Quarter 2025 Earnings Conference Call

ICON Public Limited Company Transcript: 45th Annual William Blair Growth Stock Conference

Jun 4, 2025, 11:40 AM EDT - 1 year ago

ICON Public Limited Company Transcript: 45th Annual William Blair Growth Stock Conference

ICLR Shareholders Have the Right to Lead the ICON Public Limited Company Securities Lawsuit - Contact the DJS Law Group to Discuss Your Rights - ICLR

Jun 2, 2025, 4:12 AM EDT - 1 year ago

ICLR Shareholders Have the Right to Lead the ICON Public Limited Company Securities Lawsuit - Contact the DJS Law Group to Discuss Your Rights - ICLR

ICON plc to Present at the William Blair 45th Annual Growth Stock Conference

May 27, 2025, 8:30 AM EDT - 1 year ago

ICON plc to Present at the William Blair 45th Annual Growth Stock Conference

ICON releases its ICON Cares 2024 Report

May 19, 2025, 4:15 PM EDT - 1 year ago

ICON releases its ICON Cares 2024 Report

Global ICON survey shows need for more efficient obesity clinical trial design to realise full potential of next-gen multi-indication therapies

May 7, 2025, 7:27 AM EDT - 1 year ago

Global ICON survey shows need for more efficient obesity clinical trial design to realise full potential of next-gen multi-indication therapies

ICON Public Limited Company Earnings Call Transcript: Q1 2025

May 1, 2025, 8:00 AM EDT - 1 year ago

ICON Public Limited Company Earnings Call Transcript: Q1 2025

ICON Reports First Quarter 2025 Results

Apr 30, 2025, 4:15 PM EDT - 1 year ago

ICON Reports First Quarter 2025 Results

CapitalMonk
CapitalMonk May. 13 at 3:21 AM
$ICLR Price: $121.94 (+2.51%) Trend: Bearish Market Bias (7D): Sideways ⚖️ Expected Range: ±0.30% RSI: 55.5 | Momentum: Moderate Volume: -47.5% vs avg Volatility: 4.64% Support: $99.06 | Resistance: $129.73 Tools used: https://www.trade-ideas.com Code: INTERSTOCK25
0 · Reply
sandeeprk
sandeeprk May. 7 at 1:42 PM
$ICLR this is going to be 200+ after ER
0 · Reply
sandeeprk
sandeeprk May. 6 at 12:22 PM
$ICLR wow
1 · Reply
sandeeprk
sandeeprk May. 5 at 4:55 PM
$ICLR on the way to 160
0 · Reply
sandeeprk
sandeeprk May. 4 at 2:56 PM
$ICLR going to 160+ after ER
0 · Reply
STACKD0E
STACKD0E May. 4 at 12:05 AM
$ICLR
0 · Reply
RedCandleRandy
RedCandleRandy May. 3 at 2:37 PM
$ICLR added
0 · Reply
sandeeprk
sandeeprk May. 1 at 8:45 PM
$ICLR why up ? are the earnings out ??
1 · Reply
StockConsultant
StockConsultant May. 1 at 1:20 PM
$ICLR Icon stock, watch for an upside gap breakout at https://stockconsultant.com/?ICLR
0 · Reply
A___A
A___A May. 1 at 12:14 AM
$ICLR weren't they supposed to release FY25 earnings today?
1 · Reply
sandeeprk
sandeeprk Apr. 29 at 11:46 AM
$ICLR https://www.businesswire.com/news/home/20260429630635/en/
1 · Reply
1986iamwallstreet
1986iamwallstreet Apr. 24 at 5:07 PM
$ICLR fraud being going on here 🩸🩸🩸🩸🩸
1 · Reply
Thai1
Thai1 Apr. 20 at 6:16 PM
$ICLR Rumor is possible IQVIA takeover. Thoughts?
0 · Reply
DonCorleone77
DonCorleone77 Apr. 16 at 5:59 PM
$ICLR ICON plc options imply 9.7% move in share price post-earnings Pre-earnings options volume in ICON plc is normal with calls leading puts 7:5. Implied volatility suggests the market is anticipating a move near 9.7%, or $11.49, after results are released. Median move over the past eight quarters is 4.6%.
0 · Reply
StockConsultant
StockConsultant Apr. 16 at 1:04 PM
$ICLR Icon stock, with an upside gap breakout, target 134+, similar setup on $GO $KD $KRRO and $OLMA stocks at https://stockconsultant.com/?ICLR
0 · Reply
LongShlong33
LongShlong33 Apr. 16 at 4:09 AM
$ICLR interesting to see the big fat cats buying this up
0 · Reply
STACKD0E
STACKD0E Apr. 11 at 2:40 AM
$ICLR 🙃✨️🚀
0 · Reply
anachartanalyst
anachartanalyst Mar. 26 at 3:02 PM
$ICLR https://anachart.com/wp-content/uploads/ana_temp/1774537300_soc-img.jpg
0 · Reply
theflynews
theflynews Mar. 26 at 8:37 AM
Icon just upgraded at BMO Capital, here's why - $ICLR - https://thefly.com/ICLR
0 · Reply
OfficialStocktwitsUser
OfficialStocktwitsUser Mar. 13 at 1:01 PM
$ICLR RSI: 46.96, MACD: -11.2775 Vol: 8.03, MA20: 102.24, MA50: 147.68 🟢 BUY - Uptrend + healthy RSI 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.
0 · Reply